Retinoblastoma Biomarker Study

Plain-language summary

This study investigates biomarkers (measurable disease-related markers) for retinoblastoma, an eye tumor seen in children. It included children treated for retinoblastoma over the past 30-plus years. It is an observational (non-phase) study and has been completed.

The summary above is a plain-language rendering of the official record. The original English title is shown for reference.

Trial details

Phase

N/A

Status

Completed

Sponsor

National Cancer Institute (NCI)

Start date

11/17/1993

Estimated completion

3/6/2024

Countries

United States

Related genes

Locations

• Bethesda, United States
• Boston, United States
• New York, United States
• Durham, United States

Eligibility criteria

Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.

* INCLUSION CRITERIA:

Children treated for retroblastoma over the past 30-plus years.